Ubs Group Ag Effector Therapeutics Inc Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Effector Therapeutics Inc stock. As of the latest transaction made, Ubs Group Ag holds 644 shares of EFTRW stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
644
Previous 1,434
55.09%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EFTRW
# of Institutions
18Shares Held
2.66MCall Options Held
72.7KPut Options Held
0-
Aristeia Capital LLC Greenwich, CT1.33MShares$00.01% of portfolio
-
Goldman Sachs Group Inc New York, NY631KShares$00.0% of portfolio
-
Whitebox Advisors LLC Minneapolis, MN298KShares$00.0% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9146KShares$00.0% of portfolio
-
Parallel Advisors, LLC64.2KShares$00.0% of portfolio